HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uwe Haberkorn Selected Research

gallium 68 PSMA-11

4/202068Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study.
1/202068Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol.
12/201968Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study.
1/201968Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.
1/201968Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients.
11/2018Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.
10/2018Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer.
8/201868Ga-PSMA PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: A Prospective, 2-Center Study.
1/2018Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT.
1/201868Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Uwe Haberkorn Research Topics

Disease

157Neoplasms (Cancer)
12/2022 - 01/2003
95Prostatic Neoplasms (Prostate Cancer)
03/2022 - 01/2005
28Neoplasm Metastasis (Metastasis)
12/2021 - 01/2003
16Melanoma (Melanoma, Malignant)
03/2021 - 12/2002
13Carcinoma (Carcinomatosis)
01/2019 - 03/2002
11Hepatocellular Carcinoma (Hepatoma)
08/2010 - 05/2003
10Glioma (Gliomas)
11/2019 - 12/2010
9Lung Neoplasms (Lung Cancer)
11/2022 - 04/2014
9Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2017 - 01/2003
8Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 08/2008
8Experimental Liver Neoplasms
01/2007 - 05/2003
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 07/2014
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2006
7Meningioma (Meningiomas)
04/2018 - 05/2005
6Lymphatic Metastasis
03/2022 - 07/2013
6Lymphoma (Lymphomas)
01/2022 - 04/2007
6Xerostomia
10/2021 - 06/2017
6Adenocarcinoma
01/2021 - 06/2011
6Glioblastoma (Glioblastoma Multiforme)
09/2020 - 03/2014
5Hypoxia (Hypoxemia)
11/2022 - 04/2011
5Pain (Aches)
04/2021 - 06/2012
5Sarcoma (Soft Tissue Sarcoma)
01/2021 - 03/2008
5Infections
11/2020 - 03/2008
5Thyroid Neoplasms (Thyroid Cancer)
08/2018 - 05/2004
5Cognitive Dysfunction
01/2016 - 06/2006
5Alzheimer Disease (Alzheimer's Disease)
01/2016 - 10/2003
4Squamous Cell Carcinoma of Head and Neck
11/2018 - 03/2009
4Breast Neoplasms (Breast Cancer)
01/2018 - 09/2005
3Head and Neck Neoplasms (Head and Neck Cancer)
09/2020 - 03/2002
3Myocardial Infarction
01/2020 - 06/2005
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 03/2016
3Transthyretin-Related Hereditary Amyloidosis
05/2014 - 12/2007
3Astrocytoma (Pilocytic Astrocytoma)
03/2014 - 11/2002

Drug/Important Bio-Agent (IBA)

51AntigensIBA
03/2022 - 02/2011
45LigandsIBA
01/2022 - 12/2002
34Peptides (Polypeptides)IBA
01/2020 - 04/2003
32Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2004
29gallium 68 PSMA-11IBA
04/2020 - 10/2013
21Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2021 - 03/2002
21Glucose (Dextrose)FDA LinkGeneric
01/2019 - 03/2002
1568Ga-FAPIIBA
12/2022 - 01/2018
15Radioisotopes (Radionuclides)IBA
10/2021 - 04/2005
12RadiopharmaceuticalsIBA
11/2022 - 09/2005
10N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
01/2018 - 04/2012
9Prostate-Specific Antigen (Semenogelase)IBA
10/2021 - 01/2012
91,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2019 - 01/2003
9Edotreotide (SMT 487)IBA
11/2017 - 01/2003
7PSMA-617IBA
02/2022 - 06/2015
7Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2014
7Somatostatin Receptors (Somatostatin Receptor)IBA
12/2021 - 01/2003
6CarbonIBA
01/2021 - 04/2013
6AntibodiesIBA
10/2020 - 11/2011
6AcidsIBA
01/2018 - 01/2005
6IodidesIBA
12/2010 - 05/2003
5FAPI-46IBA
01/2022 - 01/2020
5IntegrinsIBA
01/2021 - 12/2011
5IpilimumabIBA
01/2021 - 03/2015
5IonsIBA
01/2021 - 01/2018
5BombesinIBA
01/2018 - 01/2005
5Urea (Carbamide)FDA LinkGeneric
01/2016 - 04/2012
5BenzamidesIBA
01/2014 - 12/2002
5sodium-iodide symporter (sodium iodide symporter)IBA
12/2010 - 05/2003
4Dihydrotachysterol (AT 10)IBA
12/2022 - 01/2007
4DNA (Deoxyribonucleic Acid)IBA
11/2022 - 03/2005
4Hormones (Hormone)IBA
11/2021 - 01/2016
4SFITGv6 peptideIBA
01/2021 - 08/2017
4Protons (Proton)IBA
01/2021 - 04/2004
4Fluorine-18IBA
12/2018 - 03/2002
4benzamideIBA
07/2018 - 12/2002
4Melanins (Melanin)IBA
07/2018 - 10/2005
4Cetuximab (Erbitux)FDA Link
07/2018 - 07/2011
4Bombesin Receptors (Bombesin Receptor)IBA
01/2018 - 04/2005
4AlbuminsIBA
01/2017 - 01/2005
4Pharmaceutical PreparationsIBA
10/2016 - 03/2009
4Carbonic Anhydrase IXIBA
10/2012 - 12/2010
4ElementsIBA
12/2006 - 12/2002
3Amino AcidsFDA Link
11/2022 - 04/2004
3Immunoconjugates (Immunoconjugate)IBA
10/2022 - 03/2016
3Therapeutic UsesIBA
01/2022 - 05/2006
3Chelating AgentsIBA
10/2021 - 01/2016
3EnzymesIBA
07/2019 - 12/2010
3AndrogensIBA
01/2019 - 07/2017
3Rituximab (Mabthera)FDA Link
10/2018 - 03/2016
3Ga(III)-DOTATOCIBA
04/2018 - 05/2010
3Biological ProductsIBA
01/2018 - 05/2005
3Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 01/2005
3Peptide Receptors (Peptide Receptor)IBA
05/2016 - 06/2007
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2010 - 05/2005

Therapy/Procedure

98Therapeutics
11/2022 - 03/2002
35Radiotherapy
02/2021 - 11/2002
21Castration
12/2021 - 07/2014
17Drug Therapy (Chemotherapy)
01/2021 - 12/2006
10Precision Medicine
01/2022 - 06/2015
7Immunotherapy
03/2021 - 04/2014
7Prostatectomy (Retropubic Prostatectomy)
01/2021 - 03/2017
5Radioimmunotherapy
01/2019 - 07/2011
4Lymph Node Excision (Lymph Node Dissection)
01/2021 - 07/2013
3Re-Irradiation
10/2018 - 04/2013
3Neoadjuvant Therapy
03/2013 - 04/2010
3Chemoradiotherapy
06/2011 - 04/2007